BHG vs. NEUE, MLSS, BOLT, ADEX, NRXP, CALC, JATT, CTCX, RMTI, and DARE
Should you be buying Bright Health Group stock or one of its competitors? The main competitors of Bright Health Group include NeueHealth (NEUE), Milestone Scientific (MLSS), Bolt Biotherapeutics (BOLT), Adit EdTech Acquisition (ADEX), NRx Pharmaceuticals (NRXP), CalciMedica (CALC), JATT Acquisition (JATT), Carmell (CTCX), Rockwell Medical (RMTI), and Daré Bioscience (DARE). These companies are all part of the "medical" sector.
NeueHealth (NYSE:NEUE) and Bright Health Group (NYSE:BHG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations.
NeueHealth currently has a consensus price target of $8.00, indicating a potential upside of 36.99%. Bright Health Group has a consensus price target of $13.00, indicating a potential upside of 119.97%. Given NeueHealth's higher possible upside, analysts clearly believe Bright Health Group is more favorable than NeueHealth.
NeueHealth has a net margin of -71.23% compared to NeueHealth's net margin of -85.40%.
In the previous week, NeueHealth had 12 more articles in the media than Bright Health Group. MarketBeat recorded 13 mentions for NeueHealth and 1 mentions for Bright Health Group. NeueHealth's average media sentiment score of 0.67 beat Bright Health Group's score of 0.15 indicating that Bright Health Group is being referred to more favorably in the news media.
Bright Health Group received 15 more outperform votes than NeueHealth when rated by MarketBeat users. Likewise, 30.00% of users gave Bright Health Group an outperform vote while only 0.00% of users gave NeueHealth an outperform vote.
63.9% of NeueHealth shares are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 58.4% of Bright Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
NeueHealth has higher earnings, but lower revenue than Bright Health Group. NeueHealth is trading at a lower price-to-earnings ratio than Bright Health Group, indicating that it is currently the more affordable of the two stocks.
NeueHealth has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Bright Health Group has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.
Summary
NeueHealth beats Bright Health Group on 9 of the 16 factors compared between the two stocks.
Get Bright Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for BHG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bright Health Group Competitors List
Related Companies and Tools
